Head and neck cancer a type of cancer linked to tobacco smoking or alcohol. This can affect the oral cavity, pharynx, larynx, hypopharynx, cervical esophagus, nose, and paranasal sinuses. The treatment of head and neck surgery consists of radiotherapy, chemotherapy, or a combination of these. Radiation therapy for squamous cell carcinoma involves the delivery of high-energy ionizing radiation to targeted tissues. Chemotherapy for squamous cell carcinoma of the head and neck involves the systemic administration of cytotoxic drugs which targets rapidly dividing the cells. Other therapy methods for head and neck cancer include photosensitizers and interstitial laser therapy, photodynamic therapy, immune therapy, gene therapy, and targeted therapy against epidermal growth factor receptor and human papillomavirus.
Dr. Ryan F. Osborne, MD FACS, is the Director at the Osborne Head and Neck Institute. Dr. Osborne has an internationally renowned expert in head and neck oncology. He has completed his fellowship in advanced head and neck oncology under the mentorship of world expert – Thomas Calcaterra, MD at UCLA Medical Center. The mission of the Osborne Head and Neck Foundation is to create a center of excellence where patients comprehensive needs are delivered. Dr. Osborne has traveled all over the United States, Asia, and Europe to exchange his ideas with other surgeons having similar goals.
The symptoms of head and neck cancer are variable and depend on the stage of the tumor. It also includes –
• Blood in saliva
• A lump or swelling in head or neck
• Changes in voice
• Pain in swallowing or breathing
• Nasal obstruction
• A mass in the neck
This treatment of head and neck squamous cell carcinoma (HNSCC) often leaves the patient with many deficits like speech and swallowing. CT scan or integrated fluorodeoxyglucose positron emission tomography (FDG-PET/CT) is required before treatment for patients with head and neck cancer disease. A high percentage of cure is possible at the early stage of head and neck squamous cell carcinoma.
Multiple factors may contribute to HNSCC development apart from the established risk factors. The analysis of the disease stage is important to carry different types is treatment. The various treatment such as surgery, chemotherapy, radiotherapy, and chemoradiotherapy at such stages may impair the life of patients and mutilation of a specific organ. Continuous intervention of new insights will improve further understanding of head and neck cancer surgery.
Contact details: 310-657-0123